Forglyn Plus Respicaps Capsule

Forglyn Plus Respicaps Capsule is a triple-combination inhalation therapy designed for the effective management of moderate to severe Chronic Obstructive Pulmonary Disease (COPD) and asthma. It combines three powerful agents that target different mechanisms in airway obstruction — Budesonide, a corticosteroid; Formoterol, a long-acting β?-agonist (LABA); and Glycopyrrolate, a long-acting muscarinic antagonist (LAMA). Together, they deliver broad-spectrum respiratory control by reducing inflammation, relaxing airway muscles, and preventing bronchospasm.

Budesonide acts by decreasing swelling and irritation in the airways, making it easier to breathe. Formoterol provides quick and sustained bronchodilation, helping open the airways for up to 12 hours. Glycopyrrolate complements these actions by blocking cholinergic receptors in the bronchial muscles, preventing tightening and promoting smoother airflow. This triple therapy provides superior symptom control and lung function improvement compared to dual-drug combinations.